135 related articles for article (PubMed ID: 22540943)
1. Negative regulation of the type I interferon signaling pathway by synthetic Toll-like receptor 7 ligands.
Forsbach A; Müller C; Montino C; Kritzler A; Nguyen T; Weeratna R; Jurk M; Vollmer J
J Interferon Cytokine Res; 2012 Jun; 32(6):254-68. PubMed ID: 22540943
[TBL] [Abstract][Full Text] [Related]
2. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
[TBL] [Abstract][Full Text] [Related]
3. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells.
Gautier G; Humbert M; Deauvieau F; Scuiller M; Hiscott J; Bates EE; Trinchieri G; Caux C; Garrone P
J Exp Med; 2005 May; 201(9):1435-46. PubMed ID: 15851485
[TBL] [Abstract][Full Text] [Related]
4. Antiviral protein Viperin promotes Toll-like receptor 7- and Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells.
Saitoh T; Satoh T; Yamamoto N; Uematsu S; Takeuchi O; Kawai T; Akira S
Immunity; 2011 Mar; 34(3):352-63. PubMed ID: 21435586
[TBL] [Abstract][Full Text] [Related]
5. The unique role of STAT2 in constitutive and IFN-induced transcription and antiviral responses.
Blaszczyk K; Nowicka H; Kostyrko K; Antonczyk A; Wesoly J; Bluyssen HA
Cytokine Growth Factor Rev; 2016 Jun; 29():71-81. PubMed ID: 27053489
[TBL] [Abstract][Full Text] [Related]
6. TRIM35 negatively regulates TLR7- and TLR9-mediated type I interferon production by targeting IRF7.
Wang Y; Yan S; Yang B; Wang Y; Zhou H; Lian Q; Sun B
FEBS Lett; 2015 May; 589(12):1322-30. PubMed ID: 25907537
[TBL] [Abstract][Full Text] [Related]
7. Dual or triple activation of TLR7, TLR8, and/or TLR9 by single-stranded oligoribonucleotides.
Forsbach A; Samulowitz U; Völp K; Hofmann HP; Noll B; Tluk S; Schmitz C; Wader T; Müller C; Podszuweit A; Lohner A; Curdt R; Uhlmann E; Vollmer J
Nucleic Acid Ther; 2011 Dec; 21(6):423-36. PubMed ID: 22196370
[TBL] [Abstract][Full Text] [Related]
8. Recognition of Borrelia burgdorferi, the Lyme disease spirochete, by TLR7 and TLR9 induces a type I IFN response by human immune cells.
Petzke MM; Brooks A; Krupna MA; Mordue D; Schwartz I
J Immunol; 2009 Oct; 183(8):5279-92. PubMed ID: 19794067
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
Uematsu S; Sato S; Yamamoto M; Hirotani T; Kato H; Takeshita F; Matsuda M; Coban C; Ishii KJ; Kawai T; Takeuchi O; Akira S
J Exp Med; 2005 Mar; 201(6):915-23. PubMed ID: 15767370
[TBL] [Abstract][Full Text] [Related]
10. Bruton's tyrosine kinase regulates TLR9 but not TLR7 signaling in human plasmacytoid dendritic cells.
Wang J; Lau KY; Jung J; Ravindran P; Barrat FJ
Eur J Immunol; 2014 Apr; 44(4):1130-6. PubMed ID: 24375473
[TBL] [Abstract][Full Text] [Related]
11. IL-4 suppresses the responses to TLR7 and TLR9 stimulation and increases the permissiveness to retroviral infection of murine conventional dendritic cells.
Sriram U; Xu J; Chain RW; Varghese L; Chakhtoura M; Bennett HL; Zoltick PW; Gallucci S
PLoS One; 2014; 9(1):e87668. PubMed ID: 24489947
[TBL] [Abstract][Full Text] [Related]
12. Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand.
Marshall JD; Heeke DS; Gesner ML; Livingston B; Van Nest G
J Leukoc Biol; 2007 Sep; 82(3):497-508. PubMed ID: 17565046
[TBL] [Abstract][Full Text] [Related]
13. Type I IFN-mediated synergistic activation of mouse and human DC subsets by TLR agonists.
Kreutz M; Bakdash G; Dolen Y; Sköld AE; van Hout-Kuijer MA; de Vries IJ; Figdor CG
Eur J Immunol; 2015 Oct; 45(10):2798-809. PubMed ID: 26255864
[TBL] [Abstract][Full Text] [Related]
14. TLR2 signaling depletes IRAK1 and inhibits induction of type I IFN by TLR7/9.
Liu YC; Simmons DP; Li X; Abbott DW; Boom WH; Harding CV
J Immunol; 2012 Feb; 188(3):1019-26. PubMed ID: 22227568
[TBL] [Abstract][Full Text] [Related]
15. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
Andersen JM; Al-Khairy D; Ingalls RR
Biol Reprod; 2006 May; 74(5):824-31. PubMed ID: 16421230
[TBL] [Abstract][Full Text] [Related]
16. MEKK3 activates IRF7 to trigger a potent type I interferon induction in response to TLR7/9 signaling.
Cai M; Huang W; Hu X; Chen A; Zhou X
Mol Immunol; 2021 Jun; 134():183-191. PubMed ID: 33812250
[TBL] [Abstract][Full Text] [Related]
17. An anti-interferon activity shared by paramyxovirus C proteins: inhibition of Toll-like receptor 7/9-dependent alpha interferon induction.
Yamaguchi M; Kitagawa Y; Zhou M; Itoh M; Gotoh B
FEBS Lett; 2014 Jan; 588(1):28-34. PubMed ID: 24269682
[TBL] [Abstract][Full Text] [Related]
18. Critical role of IkappaB Kinase alpha in TLR7/9-induced type I IFN production by conventional dendritic cells.
Hoshino K; Sasaki I; Sugiyama T; Yano T; Yamazaki C; Yasui T; Kikutani H; Kaisho T
J Immunol; 2010 Apr; 184(7):3341-5. PubMed ID: 20200270
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor and RIG-I-like receptor signaling.
Kawai T; Akira S
Ann N Y Acad Sci; 2008 Nov; 1143():1-20. PubMed ID: 19076341
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of a functional, alternatively spliced Toll-like receptor 7 (TLR7) and genomic disruption of TLR8 in chickens.
Philbin VJ; Iqbal M; Boyd Y; Goodchild MJ; Beal RK; Bumstead N; Young J; Smith AL
Immunology; 2005 Apr; 114(4):507-21. PubMed ID: 15804288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
